Join Our Study: Help Advance Preeclampsia Screening

We are conducting a study where patient samples and information obtained from this study are intended to be used to develop a screening test in singleton pregnant people, 18 years or older, to assess the risk of developing preterm preeclampsia before they have obvious symptoms of the condition. The patient samples and information collected from this study may be used to develop future screening tests to identify patients at high risk of developing other adverse pregnancy outcomes such as gestational diabetes, preterm birth, term preeclampsia (≥ 37 weeks’ gestation), fetal growth restriction /small for gestational age birthweight, placental abruption, placenta accreta spectrum, and stillbirth.

Sponsored by

Patrocinado por

Gesponsert von

Gesponsert von

Opdrachtgever:

Natera

Participants

Participantes

Teilnehmenden

Deelnemers:

9000

People

Personen

Participate by

Participar mediante

Abschlussdatum

Uiterlijke Inschrijving:

May 1, 2026

1.5.2026

1.5.2026

1.5.2026

Who is the study for? 

You may qualify if:

  • Pregnant person with a single living fetus at the time of enrollment 
  • 18 years or older at the time of informed consent
  • Gestational age 9+0 to 15+6 weeks (inclusive) at the time of enrollment
  • Willing and able to provide informed consent and comply with study procedures
  • Age < 20 or ≥ 35 years
  • BMI ≥ 30 kg/m2

What is expected of me? 

If you qualify and choose to participate, we will collect three small blood samples during routine prenatal visits:

  1. At enrollment (15-21 weeks)
  2. Around 21-27 weeks
  3. Around 36-42 weeks

What is the benefit for me?

  • Help advance research on preeclampsia screening and pregnancy health.
  • Contribute to the development of a test that could improve prenatal care for future mothers.
  • Compensation for participant

Join Our Study: Help Advance Preeclampsia Screening

We are conducting a study where patient samples and information obtained from this study are intended to be used to develop a screening test in singleton pregnant people, 18 years or older, to assess the risk of developing preterm preeclampsia before they have obvious symptoms of the condition. The patient samples and information collected from this study may be used to develop future screening tests to identify patients at high risk of developing other adverse pregnancy outcomes such as gestational diabetes, preterm birth, term preeclampsia (≥ 37 weeks’ gestation), fetal growth restriction /small for gestational age birthweight, placental abruption, placenta accreta spectrum, and stillbirth.

Click here to take part
Haga clic aquí para participar
Teilnehmen
Klik hier om deel te nemen

Study for

Estudio dirigido a

Zielgrupper der Studie

Onderzoek voor:

Sponsored by

Patrocinado por

Gesponsert von

Opdrachtgever:

Natera

Participants

Participantes

Teilnehmenden

Deelnemers:

9000

People

Personen

Participate by

Participar mediante

Abschlussdatum

Duur van onderzoek:

May 1, 2026

1.5.2026

1.5.2026

1.5.2026

Who is the study for? 

¿A quién va dirigido el estudio?

Für wen ist die Studie geeignet?

Voor wie is het onderzoek bedoeld?

You may qualify if:

  • Pregnant person with a single living fetus at the time of enrollment 
  • 18 years or older at the time of informed consent
  • Gestational age 9+0 to 15+6 weeks (inclusive) at the time of enrollment
  • Willing and able to provide informed consent and comply with study procedures
  • Age < 20 or ≥ 35 years
  • BMI ≥ 30 kg/m2

What is expected of me? 

¿Qué se espera de mí?

Was wird von mir erwartet?

Wat wordt van mij verwacht?

If you qualify and choose to participate, we will collect three small blood samples during routine prenatal visits:

  1. At enrollment (15-21 weeks)
  2. Around 21-27 weeks
  3. Around 36-42 weeks
Contact our study team

What is the benefit for me?

¿En qué me beneficia?

Welchen Nutzen habe ich davon?

Wat is het voordeel voor mij?

  • Help advance research on preeclampsia screening and pregnancy health.
  • Contribute to the development of a test that could improve prenatal care for future mothers.
  • Compensation for participant

Complete this questionnaire to take part.

Fülle diesen Fragebogen aus, um herauszufinden, ob Du berechtigt bist